- Home
- / SUSMED
SUSMED
Stock Price
¥596
2024-10-29
Market Capitalization
¥10 B
2024-10-29
Revenue
¥463 M
FY, 2025
SUSMED Summary
Company Summary
- Overview
- SUSMED is a digital therapeutics (DTx) development business. It offers therapeutic applications, drug development, clinical trials, medical information, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Chuo City, JP | view all locations
- Website
- https://www.susmed.co.jp
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Chuo City, Tokyo HQ
Japan
Mfpr Nihonbashi-Honcho, Bldg 10F, 3-chōme-7-2 Nihonbashihonchō
SUSMED Financials
Summary Financials
- Revenue (H1, 2026)
- ¥91.3M
- Gross profit (H1, 2026)
- ¥86.0M
- Net income (H1, 2026)
- (¥272.7M)
- Cash (H1, 2026)
- ¥4.0B
- EBIT (H1, 2026)
- (¥270.4M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026